| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |